Former RFK Jr. Adviser Accuses White House Officials of Blocking MAHA Reforms to Protect Corporate I

Calley Means, who resigned from the Trump administration in October, accused senior White House officials of undermining Robert F. Kennedy Jr.’s health agenda through industry lobbying and political fundraising considerations, calling for sweeping changes to the administration’s leadership.

By yourNEWS Media Newsroom

WASHINGTON — Former Trump administration health adviser Calley Means accused senior White House officials of obstructing the Make America Healthy Again agenda to accommodate corporate interests, alleging that political fundraising and industry pressure repeatedly took priority over promised reforms involving processed foods, pesticides and public health. Speaking on The Joe Rogan Experience in an episode released Friday, Nov. 6, Means said Health and Human Services Secretary Robert F. Kennedy Jr. had been excluded from major policy decisions affecting his department, contributing to Means’ decision to resign from the administration in late October.

Means directed much of his criticism toward departing White House Chief of Staff Susie Wiles, along with deputy chief of staff Richard Walters, presidential policy adviser Walker Barrett, political strategist James Blair and Trump pollster Tony Fabrizio. According to Politico’s reporting on the interview, Means described a White House decision-making structure in which a small group of politically influential advisers could prevent health initiatives from advancing despite support from Kennedy and the broader MAHA movement.

“These people just, and I don’t mean this like in a really dismissive way, these aren’t the best and brightest, these staffers. They have tremendous power, though,” Means told Rogan. “But they’re just like D.C., you know, they play the game, and yeah, it’s crazy.” He argued that President Donald Trump needed to “clear his house” of advisers he believed were undermining the administration’s commitments, adding, “I think he’s getting there.”

The interview was Means’ first extensive public discussion of his departure, which followed months of disputes over federal food and environmental health policies. Means had been an influential advocate for Kennedy’s MAHA movement and helped coordinate initiatives intended to address chronic disease, improve the American food supply and reduce exposure to potentially harmful ingredients. His resignation came after repeated unsuccessful attempts to secure agreement on a federal definition of ultraprocessed foods, an initiative that supporters believed could become the foundation for new labeling requirements, nutritional standards and regulatory action.

Food manufacturers opposed aspects of the effort, warning that additional restrictions could increase production costs and consumer prices during a period of heightened concern about affordability. Means disputed those objections, arguing that the administration had an obligation to provide Americans with clearer information about the ingredients and processing methods used in commercially produced foods. He characterized the delays as evidence that industry lobbying had gained excessive influence over the White House’s health agenda.

The former adviser also cited disagreements involving glyphosate, the herbicide used in Bayer’s Roundup weedkiller, as an example of what he considered interference with Kennedy’s authority. An initial White House MAHA report identified glyphosate as a possible contributor to chronic disease, prompting objections from agricultural and chemical industry representatives. A subsequent report omitted the chemical, a change Means attributed to industry pressure directed at Wiles and other senior officials.

Means described the response from industry representatives as “an almost violent reaction from industry,” alleging that administration officials subsequently supported policies favorable to glyphosate manufacturers without adequately consulting Kennedy. The controversy intensified when the White House issued an executive order emphasizing the importance of maintaining domestic production of glyphosate-based herbicides, citing national security and agricultural supply concerns.

Bayer, which acquired Monsanto and manufactures Roundup, has sought legal protections against certain lawsuits alleging that glyphosate-based products cause cancer. The administration supported Bayer’s position in litigation before the Supreme Court in Monsanto v. Durnell, prompting objections from MAHA supporters who argued that the federal government should prioritize consumer health concerns over liability protections for pesticide manufacturers. The legal dispute concerns the relationship between federal pesticide labeling requirements and state-law claims, rather than a direct judicial determination that glyphosate causes or does not cause cancer.

Means alleged that Kennedy had been excluded from discussions surrounding both the executive order and the administration’s legal position.

“Both of these things were completely done without Bobby Kennedy throughout any policy process,” Means said. “What they frequently did is they tried to take Bobby out of the discussion.”

He also accused Heidi Overton, a White House health adviser nominated to lead the Food and Drug Administration, of participating in decisions favorable to pesticide manufacturers and undermining Kennedy’s influence. Those allegations represent Means’ account of internal administration deliberations and have not been independently established as findings of misconduct. Overton’s involvement in the administration’s legal and regulatory discussions does not itself demonstrate that officials acted improperly or violated federal ethics requirements.

The dispute is particularly consequential for Kennedy’s political coalition, which supported Trump’s 2024 presidential campaign in part because of promises to challenge pharmaceutical, agricultural and food industry influence over federal health policy. MAHA supporters have sought action on food additives, school nutrition, environmental exposures and chronic disease prevention, but disagreements over the pace and scope of those changes have created tensions between activists and administration officials.

According to Axios’ coverage of Means’ allegations, the former adviser argued that a concentrated group of White House officials exercised disproportionate influence over policy decisions and that the resulting disagreements contributed directly to his resignation. He also accused political strategists of prioritizing campaign considerations over policy commitments, an allegation that emerged as Republicans assessed their losses in Tuesday’s midterm elections.

“I mean, it’s why we lost the midterms. We have been discordant from what was run on two years ago,” Means said, linking his frustration over the MAHA agenda to what he viewed as a broader failure to deliver on promises made during the 2024 campaign.

The White House has disputed the suggestion that its health agenda has been abandoned, pointing to changes in federal dietary guidelines, efforts to remove certain artificial food dyes and ingredients, and initiatives intended to support healthier food production. Administration officials have maintained that regulatory decisions must also account for agricultural requirements, economic consequences and the legal responsibilities of federal agencies.

Kennedy has continued defending the administration’s overall health reform efforts while acknowledging disagreements over industry influence. Following Wiles’ departure, he praised her service and reaffirmed his commitment to advancing MAHA priorities, indicating that he and Trump intended to continue resisting improper corporate influence over health policy.

Means’ criticism emerged on the same day Trump announced that Stephen Miller would replace Wiles as White House chief of staff beginning Monday, Nov. 9. Wiles is moving to the president’s political operation following Republican losses that gave Democrats control of both chambers of Congress. Means’ remarks did not establish that her departure resulted from disputes over MAHA policies, but the leadership change coincided with renewed demands from health advocates for greater influence over the administration’s regulatory agenda.

During the Rogan interview, excerpts of which circulated on X, Means argued that internal political calculations had repeatedly interfered with the health reform movement’s priorities. A second widely shared excerpt focused on his allegations involving glyphosate and the exclusion of Kennedy from relevant policy discussions.

The former adviser argued that the problems extended beyond individual appointments and reflected structural weaknesses in Washington’s political and regulatory processes. “Americans need to understand that if they are getting whipped up and excited about policy promises through our existing structure, they are being duped and gaslighted and lied to,” Means said. “We need to have systemic reform.”

Means’ allegations have renewed scrutiny of the relationship between political fundraising, corporate lobbying and federal health policy, but they remain contested accounts of internal government deliberations rather than established findings of corruption. With a new White House chief of staff preparing to take office and Kennedy continuing to oversee federal health policy, the administration faces renewed pressure from MAHA supporters to demonstrate progress on food regulation, pesticide oversight and the broader chronic disease prevention agenda.

Original article

Add as a preferred source on Google

Comments